SULFAMETHAZINE BISULFATE

US Previously Marketed

First approved in 1947

Details

Stereochemistry	ACHIRAL
Molecular Formula	C12H14N4O2S.H2O4S
Molecular Weight	376.409
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OS(O)(=O)=O.CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1

InChI

InChIKey=SOHZBANIDAJXHD-UHFFFAOYSA-N

InChI=1S/C12H14N4O2S.H2O4S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11;1-5(2,3)4/h3-7H,13H2,1-2H3,(H,14,15,16);(H2,1,2,3,4)

HIDE SMILES / InChI

Molecular Formula	C12H14N4O2S
Molecular Weight	278.33
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	H2O4S
Molecular Weight	98.078
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.drugbank.ca/drugs/DB01582
Curator's Comment: Description was created based on several sources, including https://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm061367.pdf | https://www.drugs.com/vet/sulfamethazine-25-solution-can.html

Sulfamethazine is a sulfonamide used to treat a variety of bacterial diseases in animals. It inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthetase (dihydrofolate synthetase).

CNS Activity

Approval Year

Targets

Primary Target	Pharmacology	Potency
Bacterial dihydropteroate synthase 44 Target ID: CHEMBL2364668 Sources: https://www.genome.jp/dbget-bin/www_bget?dr:D02436\|https://www.ncbi.nlm.nih.gov/pubmed/21084778\|https://www.drugbank.ca/drugs/DB01582\|https://www.ncbi.nlm.nih.gov/pubmed/4577373	Inhibitor 8504
UniProt: B6KBG5 (Dihydropteroate synthase) 4 Target ID: UniProt: B6KBG5 (Dihydropteroate synthase) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2298911	Inhibitor 8504	5.7 µM [IC50]
UniProt: B6KBG5 (Dihydropteroate synthase) 4 Target ID: UniProt: B6KBG5 (Dihydropteroate synthase) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2298911	Inhibitor 8504	5.7 µM [IC50]
Bacterial dihydropteroate synthase 44 Target ID: CHEMBL2364668 Sources: https://www.genome.jp/dbget-bin/www_bget?dr:D02436 \| https://www.ncbi.nlm.nih.gov/pubmed/21084778 \| https://www.drugbank.ca/drugs/DB01582 \| https://www.ncbi.nlm.nih.gov/pubmed/4577373	Inhibitor 8504

Conditions

Condition	Modality	Targets	Highest Phase	Product
Infectious diseases (veterinary) 4 Sources: http://www.inchem.org/documents/jecfa/jecmono/v25je06.htm	Curative		Approved 8583	SULMET Approved Use INDICATIONS FOR USE Turkeys For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. In turkeys for control of coccidiosis (Eimeria meleagrimitis, Eimeria adenoeides). Medicate for 2 days, then reduce amount of medication to one-half for 4 additional days. Chickens For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. In chickens for control of infectious coryza (Avibacterium paragallinarum), coccidiosis (Eimeria tenella, Eimeria necatrix), acute fowl cholera (Pasteurella multocida), and pullorum disease (Salmonella Pullorum). Medicate as follows: Infectious coryza, medicate for 2 consecutive days; acute fowl cholera and pullorum disease, medicate for 6 consecutive days; coccidiosis, medicate for 2 days, then reduce amount of medication to one-half for 4 additional days. Cattle (beef and nonlactating dairy) For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. Treatment of bacterial pneumonia and bovine respiratory disease complex (shipping fever complex) (Pasteurella species), colibacillosis (bacterial scours) (Escherichia coli), necrotic pododermatitis (foot rot) (Fusobacterium necrophorum), calf diphtheria (Fusobacterium necrophorum), acute metritis (Streptococcus species), and acute mastitis in beef cattle (Streptococcus species). Swine For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. For treatment and control of diseases caused by organisms to sulfamethazine. Treatment of porcine colibacillosis (bacterial scours) (Escherichia coli), and bacterial pneumonia (Pasteurella species).
Infectious diseases (veterinary) 4 Sources: http://www.inchem.org/documents/jecfa/jecmono/v25je06.htm	Curative		Approved 8583	SULMET Approved Use INDICATIONS FOR USE Turkeys For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. In turkeys for control of coccidiosis (Eimeria meleagrimitis, Eimeria adenoeides). Medicate for 2 days, then reduce amount of medication to one-half for 4 additional days. Chickens For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. In chickens for control of infectious coryza (Avibacterium paragallinarum), coccidiosis (Eimeria tenella, Eimeria necatrix), acute fowl cholera (Pasteurella multocida), and pullorum disease (Salmonella Pullorum). Medicate as follows: Infectious coryza, medicate for 2 consecutive days; acute fowl cholera and pullorum disease, medicate for 6 consecutive days; coccidiosis, medicate for 2 days, then reduce amount of medication to one-half for 4 additional days. Cattle (beef and nonlactating dairy) For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. Treatment of bacterial pneumonia and bovine respiratory disease complex (shipping fever complex) (Pasteurella species), colibacillosis (bacterial scours) (Escherichia coli), necrotic pododermatitis (foot rot) (Fusobacterium necrophorum), calf diphtheria (Fusobacterium necrophorum), acute metritis (Streptococcus species), and acute mastitis in beef cattle (Streptococcus species). Swine For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. For treatment and control of diseases caused by organisms to sulfamethazine. Treatment of porcine colibacillosis (bacterial scours) (Escherichia coli), and bacterial pneumonia (Pasteurella species).

Doses

Dose	Population	Adverse events
40 mg/kg single, oral Highest studied dose Dose: 40 mg/kg Route: oral Route: single Dose: 40 mg/kg Sources: https://www.ncbi.nlm.nih.gov/books/NBK396259/ https://pubmed.ncbi.nlm.nih.gov/759070	healthy Health Status: healthy Sex: M Sources: https://www.ncbi.nlm.nih.gov/books/NBK396259/ https://pubmed.ncbi.nlm.nih.gov/759070	Sources: https://www.ncbi.nlm.nih.gov/books/NBK396259/ https://pubmed.ncbi.nlm.nih.gov/759070

Overview

CYP3A4	CYP2C9	CYP2D6	hERG
inducer 1087

OverviewOther

Other Inhibitor	Other Substrate	Other Inducer
	CYP2C 16

Drug as perpetrator

Target	Modality	Activity	Metabolite	Clinical evidence
CYP3A4 2633	inducer 1966 Sources: https://pubmed.ncbi.nlm.nih.gov/11996015/	yes

Drug as victim

Target	Modality	Activity	Metabolite	Clinical evidence
CYP2C 16	substrate 4014 Sources: https://pubmed.ncbi.nlm.nih.gov/9293615/	yes [Ki 476 uM]

Sourcing

Vendor/Aggregator	ID	URL
ChEBI	CHEBI:102265	https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:102265
ChemicalBook	CB8116727	https://www.chemicalbook.com/ChemicalProductProperty_EN_CB8116727
eMolecules	474320	https://www.emolecules.com/cgi-bin/more?vid=474320
MolPort	MolPort-000-887-465	https://www.molport.com/shop/molecule-link/MolPort-000-887-465
Selleck Chemicals	sulfamethazine	http://www.selleckchem.com/products/sulfamethazine.html
ZINC	ZINC000000057494	http://zinc15.docking.org/substances/ZINC000000057494

PubMed

Title	Date	PubMed
Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA.	2006-05-15	16091289
A method for the quantification of low concentration sulfamethazine residues in milk based on molecularly imprinted clean-up and surface preconcentration at a Nafion-modified glassy carbon electrode.	2006-02-13	16239091
Proteomic analysis using an unfinished bacterial genome: the effects of subminimum inhibitory concentrations of antibiotics on Mannheimia haemolytica virulence factor expression.	2005-12	16247735
Monitoring of five sulfonamide antibacterial residues in milk by in-tube solid-phase microextraction coupled to high-performance liquid chromatography.	2005-11-02	16248539
Effects of mannan oligosaccharide and an antimicrobial product in nursery diets on performance of pigs reared on three different farms.	2005-11	16230663
Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl-coA-, PAPS- and ATP-dependent pathways.	2005-10-20	15880531
Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues.	2005-10	16273898
Dispersive solid-phase extraction for the determination of sulfonamides in chicken muscle by liquid chromatography.	2005-09-16	16130722
Preparation and evaluation of uniform-sized molecularly imprinted polymer beads used for the separation of sulfamethazine.	2005-09	15654726
Confirmation of sulfamethazine, sulfathiazole, and sulfadimethoxine residues in condensed milk and soft-cheese products by liquid chromatography/tandem mass spectrometry.	2005-07-09	16001847
Surface runoff and transport of sulfonamide antibiotics and tracers on manured grassland.	2005-07-07	15998859
[Qualification and quantification of 10 sulfonamides in animal feedstuff by high performance liquid chromatography-electrospray tandem mass spectrometry].	2005-07	16250451
Photocatalytic oxidation of sulfamethazine.	2005-07	15924956
Cross-coupling of sulfonamide antimicrobial agents with model humic constituents.	2005-06-15	16047782
Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment.	2005-06	16117111
[Effect of starvation and acetone on the enzyme systems of biotransformation and toxicity of xenobiotics--CYP2E1 substrates in rats].	2005-05-25	15909426
Triplet-sensitized photodegradation of sulfa drugs containing six-membered heterocyclic groups: identification of an SO2 extrusion photoproduct.	2005-05-15	15952367
Microbial inhibition by pharmaceutical antibiotics in different soils--dose-response relations determined with the iron(III) reduction test.	2005-04	15839561
Different behavior of tetracyclines and sulfonamides in sandy soils after repeated fertilization with liquid manure.	2005-04	15839560
Test-plot studies on runoff of sulfonamides from manured soils after sprinkler irrigation.	2005-04	15839549
European Proficiency testing of national reference laboratories for the confirmation of sulfonamide residues in muscle and milk.	2005-03	16021791
Use of sulfonamides in layers in Kampala district, Uganda and sulfonamide residues in commercial eggs.	2005-03	15843129
Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.	2005-01-15	15627487
Attenuation of gonadal response to photostimulation following ablation of neurons in the lateral septal organ of chicks.	2005-01-15	15607834
[Effect of sulphamethazine on the gene expression of FRTL-5 cells].	2005-01	15862012
Effects of sub-minimum inhibitory concentration antibiotic levels and temperature on growth kinetics and outer membrane protein expression in Mannheimia haemolytica and Haemophilus somnus.	2005-01	15745216
Effect of agricultural antibiotics on the persistence and transformation of 17beta-estradiol in a Sequatchie loam.	2005	16190018
Determination of sulfonamide residues in the tissues of food animals using automated precolumn derivatization and liquid chromatography with fluorescence detection.	2004-10-21	15493686
Administration of and withdrawal periods for sulphadimidine solution.	2004-09-18	15493612
Quantitative analysis of twelve sulfonamides in honey after acidic hydrolysis by high-performance liquid chromatography with post-column derivatization and fluorescence detection.	2004-08-20	15481463
Antibiotic residues in edible tissues and antibiotic resistance of faecal Escherichia coli in pigs from Portugal.	2004-08	15370824
Chemometric and derivative methods as flexible spectrophotometric approaches for dissolution and assaying tests in multicomponent tablets.	2004-08	15262532
Sorption of sulfonamide pharmaceutical antibiotics on whole soils and particle-size fractions.	2004-07-16	15254115
Prediction of chronic liver diseases on the basis of the N-acetyltransferase 2 phenotype.	2004-07-16	15253558
Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy.	2004-06	15198720
Validation of a confirmatory method for the determination of sulphonamides in muscle according to the European Union regulation 2002/657/EC.	2004-04-02	15065772
Quantitative assessment of the reliability of identification by high-performance liquid chromatography-mass spectrometry.	2004-03-26	15058563
[Determination of the residues of five sulfa drugs in eel by HPLC].	2004-03	15712888
Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.	2004-03	14977870
Antimicrobial use in the treatment of calf diarrhea.	2004-02-10	14765726
Automated microarray system for the simultaneous detection of antibiotics in milk.	2004-02-01	14750859
Sulfamethazine advances puberty in male chicks by effecting a rapid increase in gonadotropins.	2004-02	15123207
[Determination of the hereditary and constitutive predisposition to peritoneal commissures].	2004	15462319
Quantitative determination of trace concentrations of tetracycline and sulfonamide antibiotics in surface water using solid-phase extraction and liquid chromatography/ion trap tandem mass spectrometry.	2004	15317045
Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography-tandem mass spectrometry.	2003-12-22	14735982
Bioconcentration and elimination of sulfamethazine and its main metabolite in sturgeon (Acipenser schrenkii).	2003-12-17	14664536
3-Aminophenol as a novel coupling agent for the spectrophotometric determination of sulfonamide derivatives.	2003-12	14630242
[Determination of sulfamethazine and sulfamethoxazole in muscle of chicken by high performance liquid chromatography].	2003-11	14963923
Routine monitoring of antibiotics in water and wastewater with a radioimmunoassay technique.	2003-04-07	15276731
[Rheological and biopharmaceutical investigation of polymer drug delivery systems].	2003	15112436

Patents

Sample Use Guides

In Vivo Use Guide

Administer in drinking water to provide: Chickens 58 to 85 milligrams of sulfamethazine sodium per pound of body weight per day; turkeys 50 to 124 milligrams of sulfamethazine sodium per pound of body weight per day; depending upon the dosage, age, and class of chickens or turkeys, ambient temperature, and other factors. Administer to cattle and swine in drinking water, or as a drench, to provide 108 milligrams of sulfamethazine sodium per pound of body weight on the first day and 54 milligrams of sulfamethazine sodium per pound of body weight per day on the second, third, and fourth days of administration.

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:30:35 GMT 2025` Edited by `admin` on `Mon Mar 31 18:30:35 GMT 2025`
Record UNII	5J847L84W0
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SULFAMETHAZINE BISULFATE [GREEN BOOK]

Preferred Name

English

SULFAMETHAZINE BISULFATE

Common Name

English

SULPHAMETHAZINE BISULPHATE

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29739